Lisa Howard, a multiple myeloma survivor, credits clinical trials for helping her achieve remission. Now she is a patient advocate, guiding newly diagnosed cancer patients, particularly the black patients to explore clinical trial options. Read her story here: ow.ly/1yuP50X5Ufw

Rohan, who has acute myeloid leukemia, says he’s alive today because of federally funded research. His story is a powerful reminder: Research saves lives. Learn more: https://ow.ly/xH3q50X4EOI #Fight4Hematology #ResearchSavesLives #Leusm #HemeOnc

October marks #BreastCancerAwarenessMonth. Did you know #mammogram can detect #breastcancer in its early and most treatable stages? Sarah Shubeck, MD, MS, breast surgical oncologist at UChicago Medicine, explains both the benefits and anxieties around mammograms. Read here: ow.ly/8afs50X5Euo

For #BreastCancerAwarenessMonth, watch this video about what to expect when going for a routine mammogram. #BCAM #cancerscreening www.youtube.com/shorts/0DV8A...

Construction on our new Cancer Pavilion is progressing quickly and we're especially glad that it's being built with extra attention to the chemicals and materials being used. Learn more about these efforts & why they matter: essentialhospitals.org/uchicago-aim...

In a recent OncLive podcast, Rita Nanda, MD joins Filipa Lynce, MD to discuss the latest clinical trial and real-world data on antibody drug conjugates used in the treatment of triple negative breast cancer. @danafarber.bsky.social @onclive.bsky.social ow.ly/hAwn50X2t3h

Our growing team at @uchicagocancer.bsky.social is building on these concepts, with the goal of translating this knowledge to improved therapies for metastatic cancers. More to come! (4/4)

Team Thoracic Park is back! It’s time again for UChicago Medicine to participate in @lcrf.org annual "Free to Breathe" Chicago Walk on 10/5. To register and/or donate: visit lcrf.org/UChicago

🚨 New article alert!! 🚨 A great new piece in Annals of Oncology about the benefits of anthracyclines in certain types of #BreastCancer: www.annalsofoncology.org/article/S092... from Drs. @fredhow.bsky.social, Chen, & others!

A beautiful tribute to a giant in our field and institution, Dr. Golomb

Susan Cohn, MD, and her team are advancing neuroblastoma research through decades of work building a global, open-access data commons, enabling researchers and clinicians worldwide to share and access critical data. ow.ly/LXcO50WY9a8

Susan Cohn, MD, and her team are advancing neuroblastoma research through decades of work building a global, open-access data commons, enabling researchers and clinicians worldwide to share and access critical data. ow.ly/1h5h50WXJAG

Thanks to Dr. Polite for not only sharing the importance of #colonoscopy screening but showing us all what the process is like from start to finish! Join Dr. Polite & talk with your care team about your own screenings! www.uchicagomedicine.org/forefront/pr...

Check out the latest updates from the NCCN on NSCLC treatment guidelines, emphasizing the incorporation of immune checkpoint inhibitors and targeted therapies in the management of resectable NSCLC. ow.ly/Bfz450WVq2n

Congratulations to the UChicago/Infleqtion team who were recently announced as a Phase 1 winner for the NIH Quantum Sensing Technology Challenge!! Learn more about their project at www.challenge.gov?challenge=ni... @uchicagomedicine.bsky.social #AtTheForefront

Come join our team!!🤝 The Patnaik Lab is hiring Research Assistant Professors in developmental therapeutics & immuno-oncology to focus on therapeutics for immune-refractory cancers. Learn more/apply at apply.interfolio.com/168470

A new study published in @gynoncjnls shows that delivering care at high-resource tertiary centers may eliminate racial and socioeconomic disparities in women with treatable stage I-III endometrioid endometrial cancer. @uchicagoobgyn.bsky.social ow.ly/hWtP50WUb7F

Looking forward to the upcoming Jonas Center Cellular Therapy Symposium? Don't forget about the satellite symposium the day before, perfect for trainees and emerging scientists on your team! Registration (free of charge!) can be found at www.jonascentersymposium.com/satellite-sy...

In a new commentary Freeman et al. points out that patients with ER-low tumors may not benefit from estrogen therapy in adjuvant setting, suggesting re-evaluation of systemic treatment strategies. #ERLowBreastCancer #PrecisionMedicine @uchicagoobgyn.bsky.social ow.ly/Leto50WObj7

A new study from the University of Chicago links higher financial toxicity (FT) with lower quality of life and increased psychological distress in cancer patients, suggesting that screening for FT could improve emotional and physical well-being. @uchicagomedicine.bsky.social ow.ly/ffTK50WTmcp

In the latest #TheImmunoVerse episode, @PatrickHwuMD sits with Thomas Gajewski, MD, PhD to discuss on how the tumor microenvironment, genetics & gut microbiome shape immune responses — and the future of #immunotherapy. @moffittnews.bsky.social Listen here: ow.ly/ta0F50WQLv8

We're less than a month out from the #JonasCenterSymposium on cellular therapy! Held on campus & led by our experts, it promises to be a day of learning & community building! Co-hosted with @medicalcollegeofwi.bsky.social and @washumedicine.bsky.social!! More at www.jonascentersymposium.com

In a new study, Jing Chen, PhD, and team demonstrates that zeaxanthin, a plant-based nutrient, acts as an immunomodulator—boosting CD8+ T cell function and enhancing the effects of immunotherapy. @cellpress.bsky.social @uchicagobsd.bsky.social ow.ly/jFGo50WPJBG

🔥 Hot off the press: Jing Chen, PhD, and team published a new paper in Cell Reports Medicine demonstrating that zeaxanthin, a plant-based nutrient, is an important immunomodulator that enhances the function of CD8+ T cells. @uchicagobsd.bsky.social ow.ly/rqVV50WPaTn

In a new commentary Freeman et al. points out that patients with ER-low tumors may not benefit from estrogen therapy in adjuvant setting, suggesting re-evaluation of systemic treatment strategies. #ERLowBreastCancer #PrecisionMedicine @uchicagoobgyn.bsky.social ow.ly/Leto50WObj7

The Ovarian Cancer Research Alliance is holding an online conference about all gynecologic cancers September 15–17, 2025. It is free and open to those interested in learning about the latest research and resources. ocrahope.org/resources-su... #GynecologicCancerAwarenessMonth

UChicago researchers developed a new universal CAR, the GA1CAR, with modular split design to recognize various cancer antigens. The new CAR-T system provides precise control over how, when, and where the engineered T cells attack cancer. #UChicagoRadiationOncology&Biochemistry ow.ly/sZ5z50WNAEV

More great coverage of our cancer work nationally in Kansas!! 🗺️⚕️ @chicagotribune.com : www.chicagotribune.com/2025/08/20/u... @crainschicago.bsky.social : www.chicagobusiness.com/health-care/... #AtTheForefront #CancerCare #OncSky @adventhealth.bsky.social / @uchicagomedicine.bsky.social

UChicago Medicine is expanding its nationwide cancer network through a collaboration with AdventHealth Shawnee Mission, enhancing cancer care by offering advanced treatments, leading-edge clinical trials, and expert second opinions. @adventhealth.bsky.social ow.ly/CjPL50WJ19t.

In a new study, @canersaygin.bsky.social and colleagues show that TP53-mutant ALL is a high-risk, chemo-resistant subtype with poor survival, highlighting the need for tailored strategies. ow.ly/lvwo50WHJIr

Our faculty in the media! Dr. Ratain is quoted in a new piece on @medscape.com about treatment side effects & efforts to mitigate them-- you can read the piece at www.medscape.com/viewarticle/... #PatientAdvocacy #CancerTreatment #OncSky #MedSky

The striking artwork complements a study by Schweizer et al. in Cancer Cell, which reveals the spatial biology of tumor progression and proposes therapeutic strategies to help manage its course. @lengyel-ovca-lab.bsky.social @uchicagoobgyn.bsky.social ow.ly/a8Nn50WELrz

We are seeking a new Director for Administration and Operations, an important role that oversees our Cancer Center Support Grant. Apply here: uchicago.wd5.myworkdayjobs.com/External/job...

Exciting news in the world of TIL therapy for #melanoma: our own Dr. Olson is the #1 physician in the nation relative to the infusion of commercial TIL for metastatic melanoma & our program is #3 overall in the nation! Thanks to this team for bringing patients cutting-edge care!

Our faculty in the media (part 2)!! Our thoracic oncology team is shining, talking about new treatment regimens in NSCLC 🫁: Dr. @marinagarassino.bsky.social on @onclive.bsky.social www.onclive.com/view/new-imm... & Dr. Bestvina is on @targetedonc.bsky.social www.targetedonc.com/view/kras-in...

Our faculty in the media (part 1)! 🎥 Dr. Szmulewitz is on NBC 5 Chicago talking about the rising rates of prostate cancer as the city mourns the death of Ryne Sandberg www.nbcchicago.com/video/local/...

Proud of our cancer program for being #1 in Illinois for the 3rd year in a row!! Learn more about our USNWR rankings at www.uchicagomedicine.org/forefront/ne...

Our "Explain Cancer to Me" comic on clinical trials is officially available in 11 languages!! English, Spanish, Polish, Arabic, Mandarin (both simplified and traditional), Hindi, Urdu, Tagalog, Polish, French, & Haitian Creole can all be found at voices.uchicago.edu/communitycan...

Save the date! 🗓️ This year's #JonasCenterSymposium on cellular therapy will be September 26 here on the UChicago campus! Learn more/register at www.jonascentersymposium.com

New article alert! 🚨🚨 Dr. @anand-88-patel.bsky.social and 3rd year Hem/Onc Fellow Dr. Yates are published in Haematologica sharing the results of the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)! haematologica.org/article/view...

In a groundbreaking study published in Nature, Heide et al., demonstrate that blocking NNMT in tumor-supporting cells restores immune response & stops ovarian cancer growth, offering a new strategy for hard to treat cancers. @lengyel-ovca-lab.bsky.social @uchicagoobgyn.bsky.social ow.ly/IJIG50WuIQE

🔥 Hot off the press: In a new @nature.com study, Ernst Lengyel, MD, PhD and team show that blocking NNMT in tumor-supporting cells restores immune response & stops ovarian cancer growth, offering a new strategy to treat one of the deadliest cancers. @lengyel-ovca-lab.bsky.social ow.ly/zzfZ50Wu3UW

🚨 Our faculty in the media!! 🚨 Dr. Smith on @medscape.com weighing in on the #DLBCL debate: www.medscape.com/viewarticle/... and Dr. Kindler on @medpagetoday.bsky.social talking about surgery in #mesothelioma www.medpagetoday.com/reading-room... ‼️

Summer is the perfect time to learn more about sun safety and skin cancer prevention! Join today from 12-2!!

Very excited to share that I was selected for a 2025 National Cancer Institute Early Career Investigator Award! @uchicagocancer.bsky.social @uchicagomedicine.bsky.social reporter.nih.gov/search/OYXYV...

Very excited to share our paper investigating the evolution of therapy-related CH in myeloma pts treated w/ or w/o LEN. Can we predict the risk for second blood cancer in myeloma pts? Grateful for the collaboration with @uchicagocancer.bsky.social myeloma program. www.nature.com/articles/s41...

🔥 Hot off the press: In a new study, Cooperrider et al., show that lenalidomide drives expansion of high-risk TP53-mutant clones, which may predispose MM patients to secondary blood cancers like t-MDS and t-ALL. ow.ly/gvMO50WqIjj

A new Medical Stories segment is out/airing on @pbs.org featuring Dr. @arirosenbergmd.bsky.social & one of his patients (who is a former UChicago employee!!). It's a beautiful episode & definitely worth a watch! You can find it at medicalstories.tv/title/head-a... #HeadNeckCancer #AtTheForefront

Chuan He, PhD and team developed a powerful RNA-based liquid biopsy method that detects cancers with remarkable precision, even in its early stages. This new tool helps develop personalized treatments for various cancers. ow.ly/rMo250WnIGH

Chuan He, PhD and team developed a powerful RNA-based liquid biopsy method that detects cancers with remarkable precision, even in its early stages. This new tool helps develop personalized treatments for various cancers. ow.ly/rMo250WnIGH